Impacts of combining PD-L1 inhibitor and radiotherapy on the tumour immune microenvironment in a mouse model of esophageal squamous cell carcinoma. [PDF]
Yin Z+7 more
europepmc +1 more source
Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and <sup>177</sup>Lu-based Radioimmunotherapy of Lung Cancer. [PDF]
Kurniawan A+8 more
europepmc +1 more source
Combination Radioimmunotherapy Using 125I-MAb 425, Concomitant and Adjuvant Temozolomide (TMZ), and Radiotherapy (RT) in the Treatment of Astrocytoma with Anaplastic Foci (AAF) and Glioblastoma Multiforme (GBM): Overall Results and Recursive Partitioning Analysis (RPA) of a Phase II Pilot Study and Historical Institutional Data [PDF]
L. Li+4 more
openalex +1 more source
Adverse reaction of a combined treatment for unresectable liver cancer
Ren Jianjun, Jiang Tao, Peng Rui
doaj +1 more source
A combination of lymphatic drug delivery of anti-CTLA-4 antibody and local radiotherapy for solid-tumor treatment. [PDF]
Takagi K+4 more
europepmc +1 more source
LDRD Progress Report: Radioimmunotherapy using oxide nanoparticles: Radionuclide contaiment and mitigation of normal tissue toxicity. [PDF]
Adam J. Rondinone+3 more
openalex +1 more source
Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
Udo S. Gaipl+3 more
doaj +1 more source
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translation. [PDF]
Aguirre N+6 more
europepmc +1 more source